A383930 logo

DT&CRO CO., Ltd. Stock Price

KOSDAQ:A383930 Community·₩46.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A383930 Share Price Performance

₩3,665.00
-3315.00 (-47.49%)
₩3,665.00
-3315.00 (-47.49%)
Price ₩3,665.00

A383930 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
0 Rewards

DT&CRO CO., Ltd. Key Details

₩47.7b

Revenue

₩45.2b

Cost of Revenue

₩2.6b

Gross Profit

₩5.3b

Other Expenses

-₩2.8b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-217.23
5.35%
-5.82%
136.6%
View Full Analysis

About A383930

Founded
2017
Employees
n/a
CEO
n/a
WebsiteView website
www.dtncro.com

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.

Recent A383930 News & Updates

Recent updates

No updates